BRAF c.124_125delinsTG ;(p.A42C)

Variant ID: 7-140624379-GC-CA

NM_004333.4(BRAF):c.124_125delinsTG;(p.A42C)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Genomic and microenvironmental heterogeneity shaping epithelial-to-mesenchymal trajectories in cancer.

Nature Communications
Malagoli Tagliazucchi, Guidantonio G; Wiecek, Anna J AJ; Withnell, Eloise E; Secrier, Maria M
Publication Date: 2023-02-11

Variant appearance in text: BRAF: A42C
PubMed Link: 36774358
Variant Present in the following documents:
  • 41467_2023_36439_MOESM8_ESM.xlsx, sheet 49
View BVdb publication page



Integrative omics analyses broaden treatment targets in human cancer.

Genome Medicine
Sengupta, Sohini S; Sun, Sam Q SQ; Huang, Kuan-Lin KL; Oh, Clara C; Bailey, Matthew H MH; Varghese, Rajees R; Wyczalkowski, Matthew A MA; Ning, Jie J; Tripathi, Piyush P; McMichael, Joshua F JF; Johnson, Kimberly J KJ; Kandoth, Cyriac C; Welch, John J; Ma, Cynthia C; Wendl, Michael C MC; Payne, Samuel H SH; Fenyƶ, David D; Townsend, Reid R RR; Dipersio, John F JF; Chen, Feng F; Ding, Li L
Publication Date: 2018-07-27

Variant appearance in text: BRAF: A42C
PubMed Link: 30053901
Variant Present in the following documents:
  • 13073_2018_564_MOESM2_ESM.xlsx, sheet 2
  • 13073_2018_564_MOESM2_ESM.xlsx, sheet 8
  • 13073_2018_564_MOESM2_ESM.xlsx, sheet 19
View BVdb publication page



Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome.

British Journal Of Cancer
Thomsen, Maria M; Skovlund, Eva E; Sorbye, Halfdan H; Bolstad, Nils N; Nustad, Kjell Johannes KJ; Glimelius, Bengt B; Pfeiffer, Per P; Kure, Elin H EH; Johansen, Julia S JS; Tveit, Kjell Magne KM; Christoffersen, Thoralf T; Guren, Tormod Kyrre TK
Publication Date: 2018-06

Variant appearance in text: BRAF: A42C
PubMed Link: 29872151
Variant Present in the following documents:
  • Main text
View BVdb publication page